Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaokechuan Capsules
- Development stage
- Unknown
- Lead developer
- Chengdu Yongkon Pharmacy
- Administration
- Oral
01
Overview
Xiaokechuan Capsules (消咳喘胶囊) is an approved traditional Chinese medicine (TCM) formulated as a capsule for the treatment of cold-phlegm cough, asthma, and chronic bronchitis. Developed by Chengdu Yongkon Pharmacy, the drug is a single-herb preparation derived from *Rhododendron dauricum* leaf (Folium Rhododendri Daurici, commonly known as Manshanhong / 满山红). The active components of Manshanhong, including farrerol, rhododendrin, and volatile oils, exert antitussive, expectorant, and bronchodilating effects. It is clinically indicated for relieving cough, resolving phlegm, and alleviating asthma in patients with cold-phlegm syndrome and chronic bronchitis.
- Brand names
- JinmaYongkang
- Other names
- Xiaokechuan Capsule消咳喘胶囊
Beyond the preview
Go deeper on Xiaokechuan Capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiaokechuan Capsules.